SAMPSON Peter Brent,LIU Yong,LI Sze-Wan,FORREST Bryan T.,PAULS Heinz W.,EDWARDS Louise G.,FEHER Miklos,PATEL Narendra Kumar B.,LAUFER Radoslaw,PAN Guohua,FEHER M
申请号：
SI201131015
公开号：
SI2556071T1
申请日:
2011.04.06
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
